Peptides / SS-31 (elamipretide) / Australia
SS-31 (elamipretide) in Australia
Legal status, what it is, and the listed suppliers in Australia that list it.
Legal status in Australia
Not an approved medicine. Not listed by name in the Poisons Standard (June 2026).
As understood at 2026-09-22. Verify with the TGA.
What SS-31 (elamipretide) is
SS-31, known as elamipretide in clinical development, is a synthetic four-amino-acid peptide that concentrates in mitochondria and binds cardiolipin, a lipid of the inner mitochondrial membrane. It was developed by Stealth BioTherapeutics. In September 2025 the US FDA granted it accelerated approval, under the brand name Forzinity, for Barth syndrome, a rare genetic mitochondrial disease. That is the only approved use; its other studied uses remain investigational.
Listed suppliers in Australia
3 of the 10 suppliers we list in Australia list SS-31 (elamipretide). Listed, not endorsed: each row is the supplier’s own stated terms.